Investor Relations
About Cline
Cline Scientific AB (“Cline” or “The Company”) develops advanced cancer diagnostics and regenerative medicine treatments. Cline’s unique patented surface nanotechnology provides solutions to critical challenges for cell-based products and processes in Life Science.
Cline is driving two projects through to a clinical-stage, StemCART - a stem cell therapy for joint repair, and CellRACE- a cancer diagnostic to predict metastasis.
Read for Cline Scientific’s Articles of Association here (Swedish).
Nasdaq First North
Since June 14 2021 Cline Scientific’s class B shares have been traded on Nasdaq First North Growth Market. Before this, Cline Scientific was admitted for trading on Spotlight Stock Market on 30 March 2015.
Cline Scientific B stock is traded under the short name CLINE B.
For more detailed information about the share and graphs click here.
Financial Calendar
Bokslutskommuniké 2023
February 23 2024
Årsredovisning 2023
Week 21 (May 20 - 24)
Årsstämma 2024
June 19 2024
Halvårsrapport 2024
August 23 2024
Bokslutskommuniké 2024
February 21 2025
Financial Reports
Press Releases
Subscribe to IR News
Sign up to receive Investor Relations news via email from Cline via Cision News. Select which language(s) you would like to recieve and which types of communications.
Your information will be stored in order to continuously be able to send you the information you’ve chosen to subscribe to. Your personal information will not be shared externally and will not be used for any other purposes than to provide you with requested information. Every distribution you receive contains a link to a page where you can edit or cancel your subscription.
By clicking "Subscribe", you’ll receive an e-mail with a link that you need to follow in order to activate your subscription. If you haven’t activated your subscription within 25 days, your information will be removed from the system.
Contact Cline IR
Patrik Sundh
CEO, board member and founder
Contact Patrik
+46 (0) 703 58 50 88
patrik.sundh@clinescientific.com
Contact Cline Scientific
+46 (0) 31 387 55 55
info@clinescientific.com
clinescientific.com
Certified Advisor
Redeye AB is Cline Scientific’s Certified Adviser. As a Certified Adviser, Redeye guide and monitor the company’s compliance on Nasdaq First North Growth Market. Redeye does not own shares in Cline Scientific.
Redeye AB
Mäster Samuelsgatan 42,
103 87 Stockholm
certifiedadviser [a] redeye.se
+46 (0)8 121 576 90
www.redeye.se/